Regulation of MCP-1 and chemokine receptor 2 (CCR2) in alcoholic liver disease
MCP-1 和趋化因子受体 2 (CCR2) 在酒精性肝病中的调节
基本信息
- 批准号:7661132
- 负责人:
- 金额:$ 24.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-10 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAlcoholic HepatitisAlcoholic Liver DiseasesAlcoholsAnimal ModelBiological AssayBlood CirculationCC chemokine receptor 2CellsChemotaxisChronicCirrhosisDataDevelopmentDietDiseaseEndotoxinsExhibitsFatty LiverFatty acid glycerol estersFibrosisFunctional disorderFutureGene ExpressionHealthHepaticHumanITGAM geneImmuneInfiltrationInflammationInflammatoryInflammatory ResponseInjuryInvestigationKnockout MiceLeukocytesLightLinkLiverMacrophage ActivationMediatingMessenger RNAMolecularMonocyte Chemoattractant Protein-1MononuclearMusNecrosisOxidative StressPathogenesisPathway interactionsPatientsPatternPlayProcessProductionProteinsRegulationRoleSerumSignal PathwaySignal TransductionSiteSourceTestingTherapeutic InterventionTissuesUnited StatesWorkalcohol exposurebeta-Chemokineschemokinechemokine receptorchronic alcohol ingestioncytokinefeedingin vitro Assayinsightlongitudinal analysismacrophagemonocytemonocyte chemoattractant protein 1 receptorperipheral bloodpreventpublic health relevancereceptorresearch studytherapy development
项目摘要
DESCRIPTION (provided by applicant): The importance of innate immune cells in the pathophysiology of alcoholic liver injury is evident from animal models and human studies. Resident macrophages in the liver are activated by endotoxin in portal circulation to produce inflammatory cytokines. In addition to the pro-inflammatory cytokines, macrophages also produce chemokines that can contribute to alcoholic liver injury. Our preliminary studies show increased production of serum and liver tissue MCP-1 production after chronic alcohol feeding in mice. We also show that MCP-1 deficient mice exhibit significantly decreased liver injury after chronic alcohol feeding. Increased MCP-1 in the liver can promote monocyte/macrophage infiltration in the liver and contribute to inflammatory responses. Activation of monocyte/macrophages is pivotal to the development of alcoholic liver injury.
We hypothesize that chronic alcohol exposure induces MCP-1 in the liver and its receptor, CCR2 on circulating monocyte/macrophages facilitating their recruitment to the liver. Altered MCP-1/CCR2 signaling could thus contribute to innate immune cell-mediated alcoholic liver injury. The objectives of the current application are to determine the role of MCP-1/CCR2 axis in alcohol-induced liver injury. Specifically, our focus will be to first perform a longitudinal analysis of MCP-1 expression in the liver and correlate these changes with alterations in resident and infiltrating macrophages in the liver after chronic alcohol feeding. Next, we will analyze the MCP-1 receptor, CCR2 on circulating monocytes after chronic alcohol feeding. We will also determine the effect of chronic alcohol on chemotaxis of CCR2-expressing monocyte/macrophages in an in vitro assay. Finally, using CCR2 knock out mice we will determine the pathophysiological significance of the MCP-1/CCR2 axis in alcohol- induced fatty liver injury. To achieve these objectives, the following specific aims are proposed: 1) Determine whether MCP-1 is required for alcohol-induced liver injury and intracellular mechanisms involved and 2) Investigate the effect of chronic alcohol on CCR2, a MCP-1 receptor, on circulating monocyte/macrophages its functional significance in alcohol-induced liver injury.
Public Health Relevance: Alcoholic liver disease is a major health concern in the United States. The objectives of this application are to investigate the effect of CC-chemokine, monocyte chemoattractant protein-1 (MCP-1) and its receptor CC-chemokine receptor 2 (CCR2) on monocyte/macrophages into the liver and its contribution to the development of alcoholic liver injury. These mechanistic studies will identify the role of monocytes and macrophages and aid in developing therapies targeted to inhibit macrophage function during chronic alcohol consumption.
描述(由申请人提供):从动物模型和人类研究中可以明显看出先天免疫细胞在酒精肝损伤的病理生理学中的重要性。肝脏中的常驻巨噬细胞在门户循环中被内毒素激活以产生炎症性细胞因子。除促炎性细胞因子外,巨噬细胞还产生趋化因子,可导致酒精性肝损伤。我们的初步研究表明,小鼠慢性酒精喂养后血清和肝组织MCP-1产生的产生增加。我们还表明,MCP-1缺乏小鼠在慢性酒精喂养后表现出明显降低的肝损伤。肝脏中的MCP-1增加可以促进肝脏中的单核细胞/巨噬细胞浸润,并导致炎症反应。单核细胞/巨噬细胞的激活对于酒精肝损伤的发展至关重要。
我们假设慢性酒精暴露会在肝脏及其受体中诱导MCP-1循环单核细胞/巨噬细胞的CCR2促进其促进肝脏的募集。因此,MCP-1/CCR2信号的改变可能导致先天免疫细胞介导的酒精肝损伤。当前应用的目标是确定MCP-1/CCR2轴在酒精诱导的肝损伤中的作用。具体而言,我们的重点是首先对肝脏中的MCP-1表达进行纵向分析,并将这些变化与慢性酒精喂养后肝脏中常驻巨噬细胞的变化相关。接下来,我们将在慢性酒精喂养后分析MCP-1受体,CCR2。我们还将在体外测定中确定慢性酒精对表达CCR2单核细胞/巨噬细胞的趋化性的影响。最后,使用CCR2敲除小鼠,我们将确定MCP-1/CCR2轴在酒精诱导的脂肪肝损伤中的病理生理意义。为了实现这些目标,提出了以下特定目标:1)确定酒精诱导的肝损伤和涉及的细胞内机制是否需要MCP-1,2)研究慢性酒精对CCR2的影响,MCP-1受体对MCP-1受体对循环单核细胞/巨噬细胞在酒精诱导的肝损伤中其功能意义。
公共卫生相关性:酒精性肝病是美国的主要健康问题。该应用的目的是研究CC-化学因子,单核细胞趋化蛋白-1(MCP-1)及其受体CC-化学受体2(CCR2)对单核细胞/巨噬细胞及其对肝脏的影响及其对肝脏的影响酒精肝损伤。这些机械研究将确定单核细胞和巨噬细胞的作用,并有助于开发旨在抑制长期饮酒期间巨噬细胞功能的疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pranoti Mandrekar其他文献
Pranoti Mandrekar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pranoti Mandrekar', 18)}}的其他基金
Role of Intestinal Proteostasis mediator HSP90 in alcoholic liver disease.
肠道蛋白质稳态介质 HSP90 在酒精性肝病中的作用。
- 批准号:
10317749 - 财政年份:2021
- 资助金额:
$ 24.68万 - 项目类别:
Role of Intestinal Proteostasis mediator HSP90 in alcoholic liver disease.
肠道蛋白质稳态介质 HSP90 在酒精性肝病中的作用。
- 批准号:
10493334 - 财政年份:2021
- 资助金额:
$ 24.68万 - 项目类别:
Targeting proteotoxic stress responses in liver fibrosis
靶向肝纤维化中的蛋白毒性应激反应
- 批准号:
10027444 - 财政年份:2019
- 资助金额:
$ 24.68万 - 项目类别:
Targeting proteotoxic stress responses in liver fibrosis
靶向肝纤维化中的蛋白毒性应激反应
- 批准号:
9333852 - 财政年份:2017
- 资助金额:
$ 24.68万 - 项目类别:
Targeting proteotoxic stress responses in liver fibrosis
靶向肝纤维化中的蛋白毒性应激反应
- 批准号:
9900686 - 财政年份:2017
- 资助金额:
$ 24.68万 - 项目类别:
Role of heat shock protein 90 in alcoholic liver disease
热休克蛋白 90 在酒精性肝病中的作用
- 批准号:
7741184 - 财政年份:2009
- 资助金额:
$ 24.68万 - 项目类别:
Role of heat shock protein 90 in alcoholic liver disease
热休克蛋白 90 在酒精性肝病中的作用
- 批准号:
8497550 - 财政年份:2009
- 资助金额:
$ 24.68万 - 项目类别:
Heat shock protein 90 in alcoholic liver disease: targeting macrophage function
酒精性肝病中的热休克蛋白 90:针对巨噬细胞功能
- 批准号:
9094393 - 财政年份:2009
- 资助金额:
$ 24.68万 - 项目类别:
Heat shock protein 90 in alcoholic liver disease: targeting macrophage function
酒精性肝病中的热休克蛋白 90:针对巨噬细胞功能
- 批准号:
9302598 - 财政年份:2009
- 资助金额:
$ 24.68万 - 项目类别:
Heat shock protein 90 in alcoholic liver disease: targeting macrophage Function
酒精性肝病中的热休克蛋白 90:靶向巨噬细胞功能
- 批准号:
10522788 - 财政年份:2009
- 资助金额:
$ 24.68万 - 项目类别:
相似国自然基金
肝细胞源性外泌体miR-192通过抑制Rictor激活巨噬细胞诱导非酒精性脂肪性肝炎的机制研究
- 批准号:81900508
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
红景天苷调节T淋巴细胞功能抑制NAFLD/NASH炎症反应的作用与机制研究
- 批准号:31800660
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
“肠道菌群-D型氨基酸代谢-氧化应激”在非酒精性脂肪性肝炎发病机制中的作用研究
- 批准号:81770571
- 批准年份:2017
- 资助金额:54.0 万元
- 项目类别:面上项目
从“NLRP3/IL-1β”信号通路探究心理应激在NASH发病中的作用及四逆散的干预机制
- 批准号:81774122
- 批准年份:2017
- 资助金额:50.0 万元
- 项目类别:面上项目
Ghrelin改善非酒精性脂肪性肝炎(NASH)的作用和机制
- 批准号:81700516
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
BEASTS-Novel Biomimetic Liver Platform for Enabling ALD Researchers
BEASTS-为 ALD 研究人员提供支持的新型仿生肝脏平台
- 批准号:
10697452 - 财政年份:2023
- 资助金额:
$ 24.68万 - 项目类别:
Asian American Prevention Research: A Populomics Epidemiology Cohort (ARISE)
亚裔美国人预防研究:人口组学流行病学队列 (ARISE)
- 批准号:
10724884 - 财政年份:2023
- 资助金额:
$ 24.68万 - 项目类别:
Development of an Interactive Bioethics Training Module for Healthcare Providers Treating Patients Who Need Liver Transplant for Alcohol-associated Liver Disease
为治疗酒精相关性肝病需要肝移植的患者的医疗保健提供者开发交互式生物伦理学培训模块
- 批准号:
10785093 - 财政年份:2023
- 资助金额:
$ 24.68万 - 项目类别:
1/4-The INTEGRATE Study: Evaluating INTEGRATEd Care to Improve Biopsychosocial Outcomes of Early Liver Transplantation for Alcohol-Associated Liver Disease
1/4-综合研究:评估综合护理以改善酒精相关性肝病早期肝移植的生物心理社会结果
- 批准号:
10712618 - 财政年份:2023
- 资助金额:
$ 24.68万 - 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
- 批准号:
10840220 - 财政年份:2023
- 资助金额:
$ 24.68万 - 项目类别: